Rosuvastatin 20 mg + Fenofibrate 160 mg Tablet (Rosuron-F 20/160)
Rosuvastatin 20 mg + Fenofibrate 160 mg
| Composition | Rosuvastatin 20 mg + Fenofibrate 160 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 10 (Alu-Alu) |
| MRP | ₹ 2550 |
| Therapy | Cardiac + Diabetic — HMG-CoA reductase inhibitor + antiplatelet / lipid combination |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Rosuron-F 20/160 (rosuvastatin 20 mg + fenofibrate 160 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
About Rosuron-F 20/160 Tablet
Rosuron-F 20/160 Tablet contains Rosuvastatin 20 mg + Fenofibrate 160 mg. Rosuvastatin is among the most potent statins; combinations with antiplatelets (Aspirin, Clopidogrel) and lipid-modifiers (Ezetimibe, Fenofibrate) provide comprehensive cardiovascular risk reduction.
Indicated for primary hyperlipidaemia, mixed dyslipidaemia, secondary prevention of cardiovascular events, and as primary prevention in high-risk patients (JUPITER trial).
Camrut Healthcare manufactures the Rosuron range under WHO-GMP conditions for PCD pharma franchise across India.
Rosuron-F 20/160 का उपयोग (हिंदी में): कोलेस्ट्रॉल कम करने की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Indications
- Primary hypercholesterolaemia
- Mixed dyslipidaemia
- Secondary prevention of CV events
- Primary prevention in high-risk patients
- Familial hypercholesterolaemia
Mechanism of Action
Rosuvastatin is a potent statin that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Hepatic LDL receptor upregulation increases LDL clearance from blood. Produces 40-55% LDL reduction at 10-40 mg doses with modest HDL increase. Fenofibrate reduces triglycerides via PPAR-alpha activation.
Dosage & Administration
['Adults: 1 tablet once daily at any time of day', 'Take with or without food', 'Titrate based on lipid response', 'Monitor LFT and CK as advised']
Side Effects
['Myalgia and muscle pain', 'Elevated liver enzymes', 'GI upset', 'Headache', 'Rhabdomyolysis (rare; immediate medical attention)']
Contraindications & Precautions
['Active liver disease', 'Pregnancy and breastfeeding', 'Concurrent ciclosporin (rosuvastatin)', 'Severe renal impairment (with high-dose rosuvastatin)']
Storage
Store below 25°C.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the cardiac diabetic pharma franchise product list. See our full tablet range for PCD franchise. No franchise fee; minimum first order ₹25,000 – cost and documents.
Rosuron-F 20/160 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products
